Sort
16,300 grants matching “fatty liver disease”
HTS of Compounds Modulating PGC-1a Acetylation and Oxidative Metabolic Function
$43,750Pere Puigserver · Dana-Farber Cancer Inst · R03 · FY2011 · DA
Uncovering the mechanistic drivers of hepatic dysfunction in LIPT1 deficiency
$43,691Margaret Brecker Cervantes · Ut Southwestern Medical Center · F30 · FY2025 · DK
Role of Vascular Chemerin as a Regulator of Blood Pressure and Contributor to Cardiovascular Disease
$43,690Emma Wabel · Henry Ford Health + Michigan State University Health Sciences · F31 · FY2024 · HL
INVESTIGATOR INITIATED STUDY OF THE EFFECTS OF ANDROGEN THERAPY ON CARBOHYDRA
$43,610Fred R Sattler · University Of Southern California · M01 · FY2007 · RR
In vivo imaging to evaluate the effect of PUFAs on alcoholic fatty liver disease
$43,576Vanessa Helen Quinlivan-Repasi · Johns Hopkins University · F31 · FY2016 · AA
SRC-2 and AMPKa2 in liver metabolism and Non-Alcoholic Fatty Liver Disease
$43,576Tiffany C. Fleet · Baylor College Of Medicine · F31 · FY2016 · DK
Metabolic Crosstalk Between Immune Cells and the Liver in Obesity
$43,560Benjamin Mantell · University Of Pittsburgh At Pittsburgh · F30 · FY2012 · DK
Targeting HDAC11 to combat hepatocellular carcinoma and regulate alternative RNA splicing
$43,504Jenna Clements · George Washington University · F31 · FY2024 · CA
Interleukin-13 in Central Regulation of Metabolism
$43,290Mayer Marc Chalom · Tufts University Boston · F30 · FY2023 · DK
Sex Differences in T cell metabolism
$43,203Jaclyn Kline · Harvard Medical School · F31 · FY2024 · AI
Role for tissue-type plasminogen activator in suppression of hepatic fibrosis
$43,197Liang-I Kang · University Of Pittsburgh At Pittsburgh · F30 · FY2011 · DK
Targeting the hepatic adropin signaling pathway in obesity
$43,170Bellina Mushala · University Of Pittsburgh At Pittsburgh · F31 · FY2023 · DK
AdPLA function in adipose lipid metabolism
$43,138Marcia J Abbott · University Of California Berkeley · F32 · FY2011 · DK
Brown adipose tissue lysosomal and neutral lipases in nonshivering thermogenesis
$43,120Yuxi Lin · Columbia University Health Sciences · F31 · FY2015 · DK
In vivo imaging to evaluate the effect of PUFAs on alcoholic fatty liver disease
$43,120Vanessa Helen Quinlivan-Repasi · Johns Hopkins University · F31 · FY2015 · AA
The Role of Leptin in Liver Fibrogenesis
$43,067University Of Maryland Baltimore · R01 · FY2003 · DK
Hepatic SLC25a25 in Steatotic Liver Disease Progression
$43,031Elizabeth C Heintz · Lsu Pennington Biomedical Research Ctr · F31 · FY2025 · DK
Identifying novel microproteins and protein translation mechanisms involved in the development of atherosclerosis
$43,019Miranda Emiko Kelly · University Of California-Irvine · F31 · FY2025 · HL
23rd Annual International Workshop on Co-morbidities and Adverse Drug Reactions in HIV
$43,000Todd T Brown · Johns Hopkins University · R13 · FY2021 · AI
Role of Toll-like Receptor-4 in Obesity-associated HCC
$42,978Truman M Earl · Vanderbilt University · F32 · FY2007 · DK
Liver Stem Cell Response to Inflammation and Alcohol
$42,976University Of North Carolina Chapel Hill · F32 · FY2004 · AA
Regulation of metabolic stress by the Snhg3 locus.
$42,881Arthur Curtis Sletten · Washington University · F30 · FY2021 · DK
Understanding the role of O-GlcNAcylation in regulating cancer lipid metabolism
$42,840Valerie Sodi Salvatico · Drexel University · F31 · FY2015 · CA
PATHOPHYSIOLOGY OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN OBESITY
$42,834Samuel Klein · Washington University · M01 · FY2007 · RR
Over-Expression of microRNA-126 in Macrophages for Treatment of Atherosclerosis
$42,706Suzette Laing · University Of Texas Hlth Science Center · F30 · FY2015 · DE